Cargando…

Importance of FISH genetics in light chain amyloidosis

Detalles Bibliográficos
Autores principales:	Gertz, Morie A., Dispenzieri, Angela, Muchtar, Eli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669844/ https://www.ncbi.nlm.nih.gov/pubmed/29137218 http://dx.doi.org/10.18632/oncotarget.21052

Ejemplares similares

Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response
por: Grogan, Martha, et al.
Publicado: (2017)

Thermal Stability Threshold for Amyloid Formation in Light Chain Amyloidosis
por: Poshusta, Tanya L., et al.
Publicado: (2013)

Magnetic Resonance Elastography of Liver in Light Chain Amyloidosis
por: Venkatesh, Sudhakar K., et al.
Publicado: (2019)

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018
por: Gertz, Morie A.
Publicado: (2018)

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021
por: Hasib Sidiqi, M., et al.
Publicado: (2021)

Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation
por: Al Saleh, Abdullah S., et al.
Publicado: (2022)

Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis
por: Muchtar, Eli, et al.
Publicado: (2022)

Amyloid arthropathy in smoldering myeloma: Do not take it lightly
por: Muchtar, Eli, et al.
Publicado: (2021)

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis
por: Dispenzieri, Angela, et al.
Publicado: (2020)

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis
por: Warsame, Rahma, et al.
Publicado: (2020)

Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death
por: Warsame, R, et al.
Publicado: (2015)

A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis
por: Sidana, Surbhi, et al.
Publicado: (2020)

Role of Daratumumab in Cardiac AL Amyloidosis
por: Gertz, Morie A.
Publicado: (2022)

Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation
por: Sidiqi, M. Hasib, et al.
Publicado: (2018)

Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis
por: Poshusta, Tanya L., et al.
Publicado: (2009)

Prognostic Significance of Circulating Plasma Cells by Multi-Parametric Flow Cytometry in Light Chain Amyloidosis
por: Sidana, Surbhi, et al.
Publicado: (2018)

Venetoclax for the treatment of translocation (11;14) AL amyloidosis
por: Sidiqi, M. Hasib, et al.
Publicado: (2020)

Non‐cardiac biopsy sites with high frequency of transthyretin amyloidosis
por: Dasari, Surendra, et al.
Publicado: (2020)

Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome
por: Muchtar, Eli, et al.
Publicado: (2022)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

Advances in the treatment of hereditary transthyretin amyloidosis: A review
por: Gertz, Morie A., et al.
Publicado: (2019)

Should we measure clonal circulating plasma cells in light chain amyloidosis?
por: Sidana, Surbhi, et al.
Publicado: (2018)

Changes in patient-reported outcomes in light chain amyloidosis in the first year after diagnosis and relationship to NT-proBNP change
por: D’Souza, Anita, et al.
Publicado: (2021)

Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial
por: Gertz, Morie A., et al.
Publicado: (2023)

Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid‐directed monoclonal antibody
por: gertz, morie a., et al.
Publicado: (2016)

Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis
por: Gertz, Morie, et al.
Publicado: (2023)

Utility of Serum Free Light Chain Measurements in Multiple Myeloma Patients Not Achieving Complete Response to Therapy
por: Moustafa, Muhamad Alhaj, et al.
Publicado: (2015)

AL amyloidosis clonal plasma cells are regulated by microRNAs and dependent on anti‐apoptotic BCL2 family members
por: Fishov, Hila, et al.
Publicado: (2023)

Two types of amyloidosis presenting in a single patient: a case series
por: Sidiqi, M. Hasib, et al.
Publicado: (2019)

Novel Therapies in Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017)

DUAL expectations in light chain amyloidosis
por: Schönland, Stefan, et al.
Publicado: (2020)

Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation
por: Chakraborty, Rajshekhar, et al.
Publicado: (2017)

Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working Group
por: Mauermann, Michelle L., et al.
Publicado: (2023)

Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p
por: Wong, Sandy W., et al.
Publicado: (2018)

MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients
por: Mellors, Patrick W., et al.
Publicado: (2021)

Light chain amyloidosis presenting as retiform purpura
por: Soliman, Yssra S., et al.
Publicado: (2021)

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients
por: Visram, Alissa, et al.
Publicado: (2020)

Correction: MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients
por: Mellors, Patrick W., et al.
Publicado: (2021)

Light Chain (AL) Amyloidosis: The Journey to Diagnosis
por: McCausland, Kristen L., et al.
Publicado: (2017)

Localized Lymph Node Light Chain Amyloidosis
por: Dhakal, Binod, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7bvatrmp3f34f2mkoji25p2al6